SGRY Surgery Partners (SGRY) Q2 FY26 earnings call
Surgery Partners delivered strong Q2 FY26 results, exceeding revenue and adjusted EBITDA expectations, driven by robust same-facility growth and higher acuity procedures. The company is undergoing a significant portfolio optimization with the divestiture of its Idaho Falls market, aiming to streamline operations, enhance cash conversion, and strengthen its balance sheet. Management reaffirmed full-year guidance, anticipating updated figures post-transaction closing, and remains focused on disciplined capital allocation and organic growth.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.